Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chihong Zhou

2PUBLICATIONS
10CO-AUTHORS
Molecular targetsNuclear and plasma physics not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Jan 18, 2024
Simvastatin Overcomes Resistance to Tyrosine Kinase Inhibitors in Patient-derived, Oncogene-driven Lung Adenocarcinoma Models.

Weijie Ma, Sixi Wei, Qianping Li

|Jul 19, 2021
A pancreatic mixed neuroendocrine-non-neuroendocrine neoplasms (MiNEN) (NET and undifferentiated carcinoma of the pancreas with osteoclast-like giant cells) with metastatic neuroendocrine component to the liver.

Guofeng Gao, Amir Qorbani, Chihong Heidi Zhou

Pageof 1

Frequent Collaborators

1 joint publications

Guofeng Gao

1 joint publications

Amir Qorbani

1 joint publications

Weijie Ma

1 joint publications

Sixi Wei

1 joint publications

Qianping Li

1 joint publications

Jie Zeng

1 joint publications

Wenwu Xiao

1 joint publications

Ken Y Yoneda

1 joint publications

Amir A Zeki

1 joint publications

Tianhong Li

Frequent Collaborators

1 joint publications

Guofeng Gao

1 joint publications

Amir Qorbani

1 joint publications

Weijie Ma

1 joint publications

Sixi Wei

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
Application of End-to-end Anastomosis in Robotic Central Pancreatectomy
10:58

Application of End-to-end Anastomosis in Robotic Central Pancreatectomy

Published on : Jun 02, 2018

8.2K
See more related videos

Top Related Videos

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on : Jun 26, 2019

8.0K
Application of End-to-end Anastomosis in Robotic Central Pancreatectomy
10:58

Application of End-to-end Anastomosis in Robotic Central Pancreatectomy

Published on : Jun 02, 2018

8.2K
See more related videos